Sentences with phrase «called factor analysis»

Fund companies will give the credit to the genius of the manager, but there's a way you can tease out a more complete explanation: it's called factor analysis.

The fund companies will give the credit to the genius of the manager, but there's a way you can tease out a more complete explanation: it's called factor analysis.

One of the standard methods for assessing personality is to analyze people's answers to a 100 - item questionnaire with a statistical technique called factor analysis.

Not exact matches

The demographic data firm Sperling's BestPlaces based its predictions on factors including cost of living, access to transportation, infrastructure, and education, updating its analysis as the e-commerce giant continues to tease new information about the massive project called HQ2.

Synthesis calls for more effort than analysis, and requires a far more complete understanding of every factor relative to the construction of the complex from the simple; analysisdoes not.

The full analysis of an actual entity requires us to speak of a factor called creativity; along with other factors such as the ingredient eternal objects.

An in - depth genetic analysis, performed with the participation of graduate students Tal Lupo and Lihee Asaf, pointed to a gene called WNT5B, which was revealed to be the factor prompting stem cells to differentiate into lymphatic cells.

This analysis revealed that a SNP called rs9349379, located hundreds of kilobases away, was the strongest risk factor for cardiovascular disease at chromosome 6p24.

It runs the same analyses that the call centre version does (see main story), but can also factor in GPS traces, text messaging and readings from a phone's accelerometer.

Where multi-fractal scaling occurs, the authors calculated the spectrum of fractal scaling factors using a method called Multi-fractal Detrended Fluctuation Analysis.

The analysis also found that Asian / Pacific Islander women were more likely to be diagnosed with another subtype of breast cancer: so - called human epidermal growth factor receptor 2 (HER2)- overexpressing breast cancer.

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

Because many of DOT's missions, programs, and strategies are statutory in nature, parts of the strategic plan should reflect past and future activities called for by law, whereas other parts of the strategic plan should reflect important strategic decisions in response to a recent agency analysis of the OA priorities or other emerging factors.

I developed a database - driven analytical system called Forensic Vehicle Analysis, which allows me to take dark or fuzzy images and generate a list of vehicle models and years that might be a possible match based on over 50 factors, such as taillight orientation or license plate position.

The purpose of a SWOT analysis, sometimes called a SWOT matrix, is to determine both internal and external factors that make -LSB-...]

As a value investor, Marks is not a fan of technical analysis (i.e. charting) but he does stress the importance of understanding what he calls «market technicals,» or non-fundamental factors that affect the supply and demand for a security.

An analysis of global dividend policies attributed the rationale for companies to pay and raise their dividends to many factors, including communicating information, so - called «agency costs,» tax policy and a company's maturation.

In his decision, Schlosser considered an analysis called the Wigmore test, which considers a number of factors to determine if communications should be privileged.

Indeed, the EU Courts have never voiced in a systematic way the factors that must be taken into account in the context of the analysis of «all the circumstances» for the assessment of the so - called «loyalty - inducing rebates».

The reliability of the child's evidence must also be carefully considered: L.E.G. v. A.G., 2002 BCSC 1455, at para 48, calls for analysis of any specific factor that may affect reliability, including age, intelligence, maturity, the stage and hostility of litigation, and so on.

Klima, Miller, and Nunlist (2009) included additional tests — called moderator analyses — to see if any factors strengthened the likelihood that dropout prevention programs improved outcomes.

Garrard and Lipsey (2007) included additional tests — called moderator analyses — to see whether any factors, such as student variables, strengthened the likelihood that conflict resolution education (CRE) programs improved outcomes.